| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |